Natural killer cells promote early CD8 T cell responses against cytomegalovirus

PLoS Pathogens

Volumn 3, Issue 8, 2007, Pages 1152-1164

  Robbins, Scott H ^a,b,c,f   Bessou, Gilles ^a,b,c   Cornillon, Amélie ^a,b,c   Zucchini, Nicolas ^a,b,c   Rupp, Brigitte ^d   Ruzsics, Zsolt ^d   Sacher, Torsten ^d   Tomasello, Elena ^a,b,c   Vivier, Eric ^a,b,c,e   Koszinowski, Ulrich H ^d   Dalod, Marc ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS UMR6102   (France)

^d UNIVERSITY OF MUNICH   (Germany)

^e HÔPITAL DE LA CONCEPTION   (France)

^f GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DENDRITIC CELL; GENETIC ENGINEERING; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INNATE IMMUNITY; MOLECULAR INTERACTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PLASMA CELL; VIRUS MUTANT; VIRUS REPLICATION; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BETAHERPESVIRINAE; CONGENIC STRAIN; CYTOLOGY; CYTOTOXICITY; DISEASE MODEL; GERMFREE ANIMAL; HERPES VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SPLEEN; VIROLOGY;

ANIMALIA; CYTOMEGALOVIRUS; MAIZE CHLOROTIC MOTTLE VIRUS; MUS;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; HERPESVIRIDAE INFECTIONS; IMMUNITY, NATURAL; INTERFERON-ALPHA; INTERFERON-BETA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MUROMEGALOVIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; VIRUS REPLICATION;

EID: 34548422822     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0030123     Document Type: Article

References (74)

1. Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S (2003) Pathogenesis of murine cytomegalovirus infection. Microbes Infect 5: 1263-1277.
2. French AR, Yokoyama WM (2003) Natural killer cells and viral infections. Curr Opin Immunol 15: 45-51.
3. Zitvogel L, Terme M, Borg C, Trinchieri G (2006) Dendritic cell-NK cell cross-talk: Regulation and physiopathology. Curr Top Microbiol Immunol 298: 157-174.
4. Yewdell JW, Haeryfar SM (2005) Understanding presentation of viral antigens to CD8+ T cells in vivo: The key to rational vaccine design. Annu Rev Immunol 23: 651-682.
5. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: The two extremes of a wide spectrum. Nat Rev Immunol 6: 231-243.
6. Wong P, Pamer EG (2003) CD8 T cell responses to infectious pathogens. Annu Rev Immunol 21: 29-70.
7. Diefenbach A, Raulet DH (2003) Innate immune recognition by stimulatory immunoreceptors. Curr Opin Immunol 15: 37-44.
8. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E (2005) Natural-killer cells and dendritic cells: "L'union fait la force". Blood 106: 2252-2258.
9. Wesley JD, Robbins SH, Sidobre S, Kronenberg M, Terrizzi S, et al. (2005) Cutting edge: IFN-gamma signaling to macrophages is required for optimal Valpha14i NK T/NK cell cross-talk. J Immunol 174: 3864-3868.
10. Zingoni A, Sornasse T, Cocks BG, Tanaka Y, Santoni A, et al. (2004) Crosstalk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol 173: 3716-3724.
11. Assarsson E, Kambayashi T, Schatzle JD, Cramer SO, von Bonin A, et al. (2004) NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions. J Immunol 173: 174-180.
12. Liu YJ (2005) IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23: 275-306.
13. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, et al. (2003) Dendritic cell responses to early murine cytomegalovirus infection: Subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 197: 885-898.
14. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, et al. (2002) Interferon alpha/beta and interleukin 12 responses to viral infections: Pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195: 517-528.
15. Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, et al. (2005) Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus. J Immunol 175: 4000-4008.
16. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HWt (1998) Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 188: 577-588.
17. Biron CA (2001) Interferons a and b as immune regulators - A new look. Immunity 14: 661-664.
18. Theofilopoulos AN, Baccala R, Beutler B, Kono DH (2005) Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 23: 307-336.
19. Hahm B, Trifilo MJ, Zuniga EI, Oldstone MB (2005) Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22: 247-257.
20. McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, et al. (2001) Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol 75: 5965-5976.
21. Bahl K, Kim SK, Calcagno C, Ghersi D, Puzone R, et al. (2006) IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections. J Immunol 176: 4284-4295.
22. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, et al. (2007) IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104: 1371-1376.
23. Haller O, Arnheiter H, Gresser I, Lindenmann J (1979) Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med 149: 601-612.
24. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, et al. (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169: 4279-4287.
25. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G (2003) Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 171: 6466-6477.
26. Lee SH, Zafer A, de Repentigny Y, Kothary R, Tremblay ML, et al. (2003) Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice. J Exp Med 197: 515-526.
27. Scalzo AA, Brown MG, Chu DT, Heusel JW, Yokoyama WM, et al. (1999) Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics 49: 238-241.
28. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951-956.
29. Scalzo AA, Fitzgerald NA, Wallace AE, Gibbons AE, Smart YC, et al. (1992) The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J Immunol 149: 581-589.
30. Krmpotic A, Busch DH, Bubic I, Gebhardt F, Hengel H, et al. (2002) MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. Nat Immunol 3: 529-535.
31. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, et al. (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2: 1144-1150.
32. Bozza S, Bistoni F, Gaziano R, Pitzurra L, Zelante T, et al. (2006) Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood 108: 3387-3396.
33. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, et al. (2003) Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature 424: 324-328.
34. Andoniou CE, van Dommelen SL, Voigt V, Andrews DM, Brizard G, et al. (2005) Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 6: 1011-1019.
35. Sjolin H, Robbins SH, Bessou G, Hidmark Å, Tomasello E, et al. (2006) DAP12 signaling regulates plasmacytoid dendritic cell homeostasis and down modulates their function during viral infection. J Immunol 177: 2908-2916.
36. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA (2003) Functional interactions between dendritic cells and NK cells during viral infection. Nat Immunol 4: 175-181.
37. Onami TM, Harrington LE, Williams MA, Galvan M, Larsen CP, et al. (2002) Dynamic regulation of T cell immunity by CD43. J Immunol 168: 6022-6031.
38. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R (2000) Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J Exp Med 191: 1241-1246.
39. Obar JJ, Crist SG, Gondek DC, Usherwood EJ (2004) Different functional capacities of latent and lytic antigen-specific CD8 T cells in murine gammaherpesvirus infection. J Immunol 172: 1213-1219.
40. Lang A, Nikolich-Zugich J (2005) Development and migration of protective CD8+T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol 174: 2919-2925.
41. Zelinskyy G, Kraft AR, Schimmer S, Arndt T, Dittmer U (2006) Kinetics of CD8(+) effector T cell responses and induced CD4(+) regulatory T cell responses during Friend retrovirus infection. Eur J Immunol 36: 2656-2670.
42. Zelinskyy G, Robertson SJ, Schimmer S, Messer RJ, Hasenkrug KJ, et al. (2005) CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection. J Virol 79: 10619-10626.
43. Su HC, Nguyen KB, Salazar-Mather TP, Ruzek MC, Dalod MY, et al. (2001) NK cell functions restrain T cell responses during viral infections. Eur J Immunol 31: 3048-3055.
44. Rupp B, Ruzsics Z, Sacher T, Koszinowski UH (2005) Conditional cytomegalovirus replication in vitro and in vivo. J Virol 79: 486-494.
45. Moretta A (2002) Natural killer cells and dendritic cells: Rendezvous in abused tissues. Nat Rev Immunol 2: 957-964.
46. Degli-Esposti MA, Smyth MJ (2005) Close encounters of different kinds: Dendritic cells and NK cells take centre stage. Nat Rev Immunol 5: 112-124.
47. van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, et al. (2006) Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25: 835-848.
48. Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, et al. (2005) A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med 201: 1543-1553.
49. Hengel H, Koszinowski UH, Conzelmann KK (2005) Viruses know it all: New insights into IFN networks. Trends Immunol 26: 396-401.
50. Schlender J, Hornung V, Finke S, Gunthner-Biller M, Marozin S, et al. (2005) Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J Virol 79: 5507-5515.
51. Le Bon A, Durand V, Kamphuis E, Thompson C, Bulfone-Paus S, et al. (2006) Direct stimulation of T cells by type I IFN enhances the CD8+T cell response during cross-priming. J Immunol 176: 4682-4689.
52. Thompson LJ, Kolumam GA, Thomas S, Murali-Krishna K (2006) Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation. J Immunol 177: 1746-1754.
53. Aichele P, Unsoeld H, Koschella M, Schweier O, Kalinke U, et al. (2006) CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J Immunol 176: 4525-4529.
54. Bartlett EJ, Lenzo JC, Sivamoorthy S, Mansfield JP, Cull VS, et al. (2004) Type I IFN-beta gene therapy suppresses cardiac CD8+ T-cell infiltration during autoimmune myocarditis. Immunol Cell Biol 82: 119-126.
55. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, et al. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31: 429-434.
56. Ravet S, Scott-Algara D, Bonnet E, Tran HK, Tran T, et al. (2007) Distinctive NK cell receptor repertoires sustain high-level constitutive NK cell activation in HIV-exposed uninfected individuals. Blood 109: 4296-4305.
57. Scott-Algara D, Truong LX, Versmisse P, David A, Luong TT, et al. (2003) Cutting edge: Increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J Immunol 171: 5663-5667.
58. Mavilio D, Lombardo G, Kinter A, Fogli M, La Sala A, et al. (2006) Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J Exp Med 203: 2339-2350.
59. Herbeuval JP, Shearer GM (2006) HIV-1 immunopathogenesis: How good interferon turns bad. Clin Immunol 123: 121-128.
60. Silvestri G, Sodora DL, Koup RA, Paiardini M, O'Neil SP, et al. (2003) Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18: 441-452.
61. Kornfeld C, Ploquin MJ, Pandrea I, Faye A, Onanga R, et al. (2005) Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest 115: 1082-1091.
62. Dalod M, Fiorentino S, Delamare C, Rouzioux C, Sicard D, et al. (1996) Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: Correlations with various parameters of disease progression. AIDS Res Hum Retroviruses 12: 497-506.
63. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, et al. (2001) Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 193: 169-180.
64. De Boer RJ (2007) Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol 81: 2838-2848.
65. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581.
66. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
67. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
68. Draghi M, Pashine A, Sanjanwala B, Gendzekhadze K, Cantoni C, et al. (2007) NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection. J Immunol 178: 2688-2698.
69. Fuller CL, Ruthel G, Warfield KL, Swenson DL, Bosio CM, et al. (2007) NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell Microbiol 9: 962-976.
70. Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, et al. (2007) Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in severe acute respiratory syndrome (SARS) patients. J Virol 81: 8692-8706.
71. Mocikat R, Braumuller H, Gumy A, Egeter O, Ziegler H, et al. (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19: 561-569.
72. Adam C, King S, Allgeier T, Braumuller H, Luking C, et al. (2005) DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood 106: 338-344.
73. Bubic I, Wagner M, Krmpoti A, Saulig T, Kim S, et al. (2004) Gain of virulence caused by loss of a gene in murine cytomegalovirus. J Virol 78: 7536-7544.
74. Barber DL, Wherry EJ, Ahmed R (2003) Cutting edge: Rapid in vivo killing by memory CD8 T cells. J Immunol 171: 27-31.